Pune divisional commissioner Saurabh Rao and district collector Rajesh Deshmukh visited the plant on Wednesday.
Share Via Email
| A+A A- By PTI
PUNE: Biovet Pvt Ltd, an associate firm of Bharat Biotech, is confident of making a plant at Manjari in Pune fully functional for vaccine production by August- end, a senior administrative official has said.
Hyderabad-based Bharat Biotech is the manufacturer of Covaxin, one of the two vaccines being used in the nationwide COVID-19 inoculation drive.
Pune divisional commissioner Saurabh Rao and district collector Rajesh Deshmukh visited the plant on Wednesday.
The Bombay High Court recently permitted Biovet to take possession of a ready-to-use vaccine manufacturing plant, built on a 12-hectare plot at Manjari in Pune, to produce Covaxin.
Amid a political war of words between the Centre and the Delhi government over the availability of sufficient vaccines to inoculate all adults in the national capital, the central government on Thursday said it will provide all possible assistance to all companies willing to manufacture the vaccine to ramp up the supply. It, however, flagged the non-availability of a sophisticated laboratory with most vaccine makers that is necessary to produce the indigenously developed Covaxin jab. The Centre also rejected Delhi government s claim that Covaxin maker Bharat Biotech has refused to provide additional vaccine doses to the Delhi government, saying the national capital has received over 15 lakh doses of the vaccine and its role is to facilitate the states.
1493
New Delhi, May 14
Amid a political war of words between the Centre and the Delhi government over the availability of sufficient vaccines to inoculate all adults in the national capital, the central government on Thursday said it will provide all possible assistance to all companies willing to manufacture the vaccine to ramp up the supply.
It, however, flagged the non-availability of a sophisticated laboratory with most vaccine makers that is necessary to produce the indigenously developed Covaxin jab.
The Centre also rejected Delhi government s claim that Covaxin maker Bharat Biotech has refused to provide additional vaccine doses to the Delhi government, saying the national capital has received over 15 lakh doses of the vaccine and its role is to facilitate the states.
Covid second wave not affecting youth as reported: Experts
April 19, 2021
A click away: The pandemic has been a game-changer. With people forced to shut themselves at home, the internet became the place to flock to for work, study and socialise - ISTOCK.COM
A click away: The pandemic has been a game-changer. With people forced to shut themselves at home, the internet became the place to flock to for work, study and socialise - ISTOCK.COM×
RELATED
The mean age during the first wave of the pandemic was 50.4 years; it was 48.9 years during the second wave.
Key functionaries of the National Task Force for Covid-19 (NTF) on Monday said that the second wave of Covid-19 is not affecting young people more as reported in a section of the media and that no significant difference in age profile and mortality of Covid-19 patients is seen during the latest surge.